FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to pharmaceutical industry, specifically to use of agent having selective action on tumor cells, causing apoptosis therein, blocking development of autophagy and preventing formation of resistance to therapy thereof. Use of a substance which is a dry extract of medicinal hedge-hyssop leaves obtained by grinding leaves, extraction with 96 % alcohol in a water bath until boiling and boiling for 14–15 minutes, evaporation at temperature of 55–60 °C, dilution of the evaporated residue first with distilled water at temperature of 40–50 °C, then adding chloroform in ratio of 4/5 of water and 1/5 of the chloroform, cooling to room temperature and centrifugation at rate of 1500 rpm for 15 minutes, followed by separation of aqueous fraction and drying it as an agent having selective effect on tumor cells, causing apoptosis therein, blocking development of autophagy and preventing formation of resistance to therapy thereof.
EFFECT: above described application is effective as an agent possessing selective action on tumor cells, causing apoptosis in them, blocking development of autophagy and preventing formation of their resistance to therapy.
1 cl, 10 dwg, 3 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING MINIMUM EFFECTIVE CONCENTRATION OF ANTITUMOUR DRUG WHICH INHIBITS CYTOPROTECTIVE AUTOPHAGY IN VITRO | 2018 |
|
RU2693829C1 |
AGENT CAUSING IN VIVO EXPERIMENTS IN SUBSTITUTION OF TUMOR CONNECTIVE TISSUE AND TRANSFERRING TUMOR CELLS FROM G1 PHASE OF CELL CYCLE INTO REST STATE G0 | 2018 |
|
RU2731105C2 |
METHOD OF COMBINED LIVER CANCER PC-1 THERAPY IN EXPERIMENT | 2020 |
|
RU2734143C1 |
AGENT EXHIBITING WOUND HEALING ACTIVITY | 2018 |
|
RU2714930C2 |
AGENT POSSESSING ANTINEOPLASTIC AND IMMUNOMODULATORY ACTION | 2013 |
|
RU2519769C1 |
ANTIFUNGAL ACTION AGENT AGAINST CANDIDA FUNGI | 2017 |
|
RU2657779C1 |
ANTI-TUBERCULOSIS AGENT | 2017 |
|
RU2657423C1 |
MEANS, POSSESSING ANTI-TUBERCULOSIS ACTION | 2014 |
|
RU2549477C1 |
METHOD FOR IDENTIFYING COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2575828C2 |
PRODUCT FOR TREATMENT OF TUMOR CACHEXIA | 2015 |
|
RU2578440C1 |
Authors
Dates
2019-07-16—Published
2018-02-13—Filed